|
1
|
Taylor Elizabeth J: Dorland's Illustrated
medical dictionary. (29th ed.). Philadelphia, Saunders: pp.
10382000, ISBN 0721662544.
|
|
2
|
General Information About Adult Hodgkin
Lymphoma. National Cancer Institute 2014-04-23. Retrieved 20 June.
2014.
|
|
3
|
General Information About Adult
Non-Hodgkin Lymphoma. National Cancer Institute. 2014-04-25.
Retrieved 20 June. 2014.
|
|
4
|
Tsai SC, Lu CC, Lee CY, Lin YC, Chung JG,
Kuo SC, Amagaya S, Chen FN, Chen MY, Chan SF and Yang JS: AKT
serine/threonine protein kinase modulates bufalin-triggered
intrinsic pathway of apoptosis in CAL 27 human oral cancer cells.
Int J Oncol. 41:1683–1692. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Umit UM, Berna T, Handan K, Ipek E, Berrak
Y, Can E and Bahadir GM: Role of melatonin and luzindole in rat
mammary cancer. J Invest Surg. 25:345–353. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Valk PJ, Verhaak RG, Beijen MA, Erpelinck
CA, van Waalwijk van Doorn-Khosrovani Barjesteh S, Boer JM,
Beverloo HB, Moorhouse MJ, van der Spek PJ, Löwenberg B and Delwel
R.: Prognostically useful gene-expression profiles in acute myeloid
leukemia. N Engl J Med. 350:1617–1628. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cotter TG: Apoptosis and cancer: the
genesis of a research field. Nat Rev Cancer. 9:501–507. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Reed JC: Dysregulation of apoptosis in
cancer. J Clin Oncol. 17:2941–2953. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li Y, Xing D, Chen Q and Chen WR:
Enhancement of chemotherapeutic agent-induced apoptosis by
inhibition of NF-kappaB using ursolic acid. Int J Cancer.
127:462–473. 2010.PubMed/NCBI
|
|
10
|
Shi M, Lu XJ, Zhang J, Diao H, Li G, Xu L,
Wang T, Wei J, Meng W, Ma JL, et al: Oridonin, a novel lysine
acetyltransferases inhibitor, inhibits proliferation and induces
apoptosis in gastric cancer cells through p53- and
caspase-3-mediated mechanisms. Oncotarget. 7:22623–22631.
2016.PubMed/NCBI
|
|
11
|
Yang P, Zhao J, Hou L, Yang L, Wu K and
Zhang L: Vitamin E succinate induces apoptosis via the PI3K/AKT
signaling pathways in EC109 esophageal cancer cells. Mol Med Rep.
14:1531–1537. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Grund SC, Hanusch K and Wolf HU: Arsenic
and arsenic compounds, Ullmann's encyclopedia of industrial
chemistry. Weinheim: Wiley-VCH; 2005
|
|
13
|
Gielen M and Tiekink ER:
Metallotherapeutic drugs and metal-based diagnostic agents. Wiley;
pp. 2982005, ISBN 0-470-86403-6.
|
|
14
|
Zhou LY, Chen FY, Shen LJ, Wan HX and
Zhong JH: Arsenic trioxide induces apoptosis in the THP1 cell line
by downregulating EVI-1. Exp Ther Med. 8:85–90. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang S, Zhou M, Ouyang J, Geng Z and Wang
Z: Tetraarsenictetrasulfide and arsenic trioxide exert synergistic
effects on induction of apoptosis and differentiation in acute
promyelocytic leukemia cells. PLoS One. 10:e01303432015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ghaffari SH, Yousefi M, Dizaji MZ, Momeny
M, Bashash D, Zekri A, Alimoghaddam K and Ghavamzadeh A: Arsenic
trioxide induces apoptosis and incapacitates proliferation and
invasive properties of U87MG Glioblastoma cells through a Possible
NF-κB-mediated mechanism. Asian Pac J Cancer Prev. 17:1553–1564.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sun XP, Zhang X, He C, Qiao H, Jiang X,
Jiang H and Sun X: ABT-737 synergizes with arsenic trioxide to
induce apoptosis of gastric carcinoma cells in vitro and in vivo. J
Int Med Res. 40:1251–1264. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Y, Wang L, Yin C, An B, Hao Y, Wei T,
Li L and Song G: Arsenic trioxide inhibits breast cancer cell
growth via microRNA-328/hERG pathway in MCF-7 cells. Mol Med Rep.
12:1233–1238. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Walker AM, Stevens JJ, Ndebele K and
Tchounwou PB: Evaluation of arsenic trioxide potential for lung
cancer treatment: Assessment of apoptotic mechanisms and oxidative
damage. J Cancer Sci Ther. 8:1–9. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hu HT, Yao QJ, Meng YL, Li HL, Zhang H,
Luo JP, Guo CY and Geng X: Arsenic trioxide intravenous infusion
combined with transcatheter arterial chemoembolization for the
treatment of hepatocellular carcinoma with pulmonary metastasis:
Long-term outcome analysis. J Gastroenterol Hepatol. 32:295–300.
2016. View Article : Google Scholar
|
|
21
|
Ally MS, Ransohoff K, Sarin K, Atwood SX,
Rezaee M, Bailey-Healy I, Kim J, Beachy PA, Chang AL, Oro A, et al:
Effects of combined treatment with arsenic trioxide and
Itraconazole in patients with refractory metastatic basal cell
carcinoma. JAMA Dermatol. 152:452–456. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gilmore TD: Introduction to NF-kappaB:
Players, pathways, perspectives. Oncogene. 25:6680–6684. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vlahopoulos SA, Cen O, Hengen N, Agan J,
Moschovi M, Critselis E, Adamaki M, Bacopoulou F, Copland JA,
Boldogh I, et al: Dynamic aberrant NF-κB spurs tumorigenesis: A new
model encompassing the microenvironment. Cytokine Growth Factor
Rev. 26:389–403. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Monaco C, Andreakos E, Kiriakidis S, Mauri
C, Bicknell C, Foxwell B, Cheshire N, Paleolog E and Feldmann M:
Canonical pathway of nuclear factor kappa B activation selectively
regulates proinflammatory and prothrombotic responses in human
atherosclerosis. Proc Natl Acad Sci USA. 101:5634–5639. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vidal PM, Lemmens E, Dooley D and Hendrix
S: The role of ‘anti-inflammatory’ cytokines in axon regeneration.
Cytokine Growth Factor Rev. 24:1–12. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bonavita E, Galdiero MR, Jaillon S and
Mantovani A: Phagocytes as corrupted policemen in cancer-related
inflammation. Adv Cancer Res. 128:141–171. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Weniger MA and Küppers R: NF-κB
deregulation in Hodgkin lymphoma. Semin Cancer Biol. 39:32–39.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pasqualucci L and Zhang B: Genetic drivers
of NF-κB deregulation in diffuse large B-cell lymphoma. Semin
Cancer Biol. 39:26–31. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu X, Lv Y, Xie Y, Hong Q, Cai G, Zhang
S, Liu W and Chen X: Change of MAX interactor 1 expression in an
anti-Thy1 nephritis model and its effect on mesangial cell
proliferation. Cell Physial Biochem. 27:391–400. 2011. View Article : Google Scholar
|
|
30
|
Ohkubo T and Ozawa M: p120(ctn) binds to
the membrane-proximal region of the E-cadherin cytoplasmic domain
and is involved in modulation of adhesion activity. J Biol Chem.
274:21409–21415. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen GQ, Zhu J, Shi XG, Ni JH, Zhong HJ,
Si GY, Jin XL, Tang W, Li XS, Xong SM, et al: In vitro studies on
cellular and molecular mechanisms of arsenic trioxide (As2O3) in
the treatment of acute promyelocytic leukemia: As2O3 induces NB4
cell apoptosis with downregulation of Bcl-2 expression and
modulation of PML-RAR alpha/PML proteins. Blood. 88:1052–1061.
1996.PubMed/NCBI
|
|
32
|
Bazarbachi A, El-Sabban ME, Nasr R,
Quignon F, Awaraji C, Kersual J, Dianoux L, Zermati Y, Haidar JH,
Hermine O and de Thé H: Arsenic trioxide and interferon-alpha
synergize to induce cell cycle arrest and apoptosis in human T-cell
lymphotropic virus type I-transformed cells. Blood. 93:278–283.
1999.PubMed/NCBI
|
|
33
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhu XH, Shen YL, Jing YK, Cai X, Jia PM,
Huang Y, Tang W, Shi GY, Sun YP, Dai J, et al: Apoptosis and growth
inhibition in malignant lymphocytes after treatment with arsenic
trioxide at clinically achievable concentrations. J Natl Cancer
Inst. 91:772–778. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhou L, Jing Y, Styblo M, Chen Z and
Waxman S: Glutathione-s-trandferase pi inhibits As2O3-induced
apoptosis in lymphoma cells: Involvement of hydrogen peroxide
catabolism. Blood. 105:1198–1203. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Soignet SL, Maslak P, Wang ZG, Jhanwar S,
Calleja E, Dardashti LJ, Corso D, DeBlasio A, Gabrilove J,
Scheinberg DA, et al: Complete remission after treatment of acute
promyelocytic leukemia with arsenic trioxide. N Engl J Med.
339:1341–1348. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zamzami N, Hirsch T, Dallaporta B, Petit
PX and Kroemer G: Mitochondria implication in accidental and
programmed cell death: Apoptosis and necrosis. J Bioenerg Biomembr.
29:185–193. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Daj J, Weinberg RS, Waxman S and Jing Y:
Malignant cells can be sensitized to undergo growth inhibition and
apoptosis by arsenic trioxide through modulation of the glutathione
redox system. Blood. 93:268–277. 1999.PubMed/NCBI
|
|
39
|
Shen L, Chen TX, Wang YP, Lin Z, Zhao HJ,
Zu YZ, Wu G and Ying DM: As2O3 induces apoptosis of the human B
lymphoma cell line MBC-1. J Biol Regul Homeost Agents. 14:116–119.
2000.PubMed/NCBI
|
|
40
|
Korper S, Nolte F, Thiel E, Schrezenmeier
H and Rojewski MT: The role of mitochondrial targeting in arsenic
trioxide induced apoptosis in myeloid cell lines. Br J Haematol.
124:186–189. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ghaffari SH, Momeny M, Bashash D, Mirzaei
R, Ghavamzadeh A and Alimoghaddam K: Cytotoxic effect of arsenic
trioxide on acute promyelocytic leukemia cells through suppression
of NFkβ-dependent induction of hTERT due to down-regulation of Pin1
transcription. Hematology. 17:198–206. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kaileh M and Sen R: NF-κB function in B
lymphocytes. Immunol Rev. 246:254–271. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Brasier AR: The NF-kappaB regulatory
network. Cardiovasc Toxicol. 6:111–130. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Perkins ND: Integrating cell-signalling
pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol.
8:49–62. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Sun W, Guo L, Shao G, Liu X, Guan Y, Su L
and Zhao S: Suppression of LASP-1 attenuates the carcinogenesis of
prostatic cancer cell lines: Key role of the NF-κB pathway. Oncol
Rep. 37:341–347. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Bentires-Alj M, Barbu V, Fillet M, Chariot
A, Relic B, Jacobs N, Gielen J, Merville MP and Bours V: NF-kappaB
transcription factor induces drug resistance through MDR1
expression incancer cells. Oncogene. 22:90–97. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Bueso-Ramos CE, Rocha FC, Shishodia S,
Medeiros LJ, Kantarjian HM, Vadhan-Raj S, Estrov Z, Smith TL,
Nguyen MH and Aggarwal BB: Expression of constitutively active
nuclear-kappaB RelA transcription factor in blasts of acute myeloid
leukemia. Hum Pathol. 35:246–253. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Hinz M, Lemke P, Anagnostopoulos I, Hacker
C, Krappmann D, Mathas S, Dörken B, Zenke M, Stein H and
Scheidereit C: Nuclear factor kappaB-dependent gene expression
profiling of Hodgkin's disease tumor cells, pathogenetic
significance, and link to constitutive signal transducer and
activator of transcription 5a activity. J Exp Med. 196:605–617.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ghaffari SH, Yousefi M, Dizaji MZ, Momeny
M, Bashash D, Zekri A, Alimoghaddam K and Ghavamzadeh A: Arsenic
trioxide induces apoptosis and incapacitates proliferation and
invasive properties of U87MG Glioblastoma cells through a possible
NF-κB-mediated mechanism. Asian Pac J Cancer Prev. 17:1553–1564.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Lee YJ, Hwang SM, Yoon JJ, Lee SM, Kyung
EH, Kim JS, Kang DG and Lee HS: Inhibitory effect of Thuja
orientalis on TNF-α-induced vascular inflammation. Phytother Res.
24:1489–1495. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Godzich M, Hodnett M, Frank JA, Su G,
Pespeni M, Angel A, Howard MB, Matthay MA and Pittet JF: Activation
of the stress protein response prevents the development of
pulmonary edema by inhibiting VEGF cell signaling in a model of
lung ischemia-reperfusion injury in rats. Blood. 2:1519–1521.
2006.
|
|
52
|
Loennechen T, Mathisen B, Hansen J,
Lindstad RI, El-Gewely SA, Andersen K, Maelandsmo GM and Winberg
JO: Colchicine induces membrane-associated activation of matrix
metalloproteinase-2 in osteosarcoma cells in an s100A4-independent
manner. Biochem Pharmacol. 66:2341–2353. 2003. View Article : Google Scholar : PubMed/NCBI
|
